-
Abstract Number: PB1671
C-type Lectin-like Proteins D and E, but Not Botrocetin, Cause Thrombocytopenia during Bothrops jararaca Snakebite Envenomation
-
Abstract Number: PB1990
Ca2+ Release from Stores Controlled by Sarco/Endoplamic Reticulum Ca2+-ATPase 3 (SERCA3) Is Involved in Endothelial Permeability and Inflammatory Response
-
Abstract Number: PB0659
Calibrated Automated Thrombogram II: A New Thrombin Generation Test
-
Abstract Number: PB2359
Can an Effective anticoagulation Clinic Reduce Bleeding Risks?
-
Abstract Number: PB0610
Can Bone Marrow Cells Be Differentiated and Counted Using a Novel Hematology Analyzer?
-
Abstract Number: PB1315
Can we Predict the Clinical Course of Children with ITP by MPV? A Preliminary Study
-
Abstract Number: PB1334
Can we Predict the Outcome of Splenectomy for Primary Immune Thrombocytopenia? Conclusion Based on Systematic Review and Meta-Analysis
-
Abstract Number: PB1232
Canadian Guidelines Regarding Safe Blood-draw Volumes for Research in Pediatric Participants
-
Abstract Number: PB2179
Cancer Associated Thrombosis: Are DOACs a Treatment Option? Systematic Review and Meta-analysis of Randomised Controlled Trials
-
Abstract Number: PB2173
Cancer Patients Has Lower Plasmin Generation by Simultaneous Thrombin and Plasmin Assay Evaluation
-
Abstract Number: PB2177
Cancer Site and Distant Metastasis at Diagnosis Predict the Risk of VTE in Cancer
-
Abstract Number: PB0439
Canonical Signaling Pathways Dysfunctions in the Development of Major Cardiovascular Complications, Circulating Micrornas as Novel Biomarkers and their Link to Inflammation in Diabetic Patients
-
Abstract Number: PB1863
Caplacizumab in a Case of Acquired Thrombotic Thrombcytopenic Purpura (TTP) Poor Responsive to Plasma Exchange and Immunosuppressive Therapy
-
Abstract Number: PB0737
Carboxypeptidase U (CPU, TAFIa, CPB2) Generation in Acute Ischemic Stroke Patients Undergoing Thrombolysis and Endovascular Thrombectomy
-
Abstract Number: PB0137
Cardiac Myosin Promotes Thrombin Generation and Coagulation in vitro and in vivo
-
Abstract Number: PB0934
Cardiovascular Risk Factor Profile among North-Eastern Brazilian Adults with Haemophilia
-
Abstract Number: PB0071
Cardiovascular Risk in Systemic Lupus Erythematosus
-
Abstract Number: PB2194
Carrier Frequencies of Antithrombin-, Protein C-, or Protein S-deficient Variants Estimated Using a Public Database and Expression Experiments
-
Abstract Number: PB1923
Catastrophic Antiphospholipid Syndrome, Kikuchi-Fujimoto Disease and Adult-Onset Still Disease: An Unusual Association
-
Abstract Number: PB2342
Catheter-associated Thrombosis at the Hematology Center: Analysis of 2212 Medical Records from a Developing Country
-
Abstract Number: PB2143
Catheter-Associated Upper Extremities Deep Vein Thrombosis in Cancer Patients: Does Anticoagulation Time Matter?
-
Abstract Number: PB1346
CD4+ T Cell Expression of IL-10 Compared to IL-17 is Lower in Patients with Immune Thrombocytopenia (ITP) Who Do Not Respond Clinically to High Dose Corticosteroid
-
Abstract Number: OC 04.3
CD84 Links T Cell and Platelet Activity in Cerebral Thrombo-inflammation in Acute Stroke
-
Abstract Number: PB2001
Cell-free DNA and Citrullinated Histone H3 Plasma Levels Improve the Prediction of Mortality in Septic Patients
-
Abstract Number: PB0445
Cell-free DNA Is Elevated in Chronic Myeloproliferative Neoplasms: Correlation with Thrombosis and Disease Progression
-
Abstract Number: PB0722
Cellular Factor XIII Externalization in Platelets and Platelet Microparticles Induced by Receptor Mediated and Non-Receptor Mediated Platelet Activation
-
Abstract Number: PB2163
Cerebral Sinus Venous Thrombosis in Children with Leukemia: Single-institution Report
-
Abstract Number: PB2468
Cerebral Vein Thrombosis Treatment with Direct Oral Anticoagulants: A Case Series
-
Abstract Number: PB0583
Challenges in Anticoagulation Management at an Academic Medical Center, 20 Years of Clinical Observations
-
Abstract Number: PB1250
Challenges in Diagnosing and Treating Polycythemia Vera with Acquired von Willebrand Disease in a Pediatric Patient
-
Abstract Number: PB0749
Changes in Fibrinolytic Factors in a Simulated Extracorporeal Membrane Oxygenator Circuit
-
Abstract Number: PB0063
Changes in the Hemostasis System in Athletes
-
Abstract Number: PB0015
Changes of Soluble Fibrin-Monomer Complex Concentration in Different Types of Coronary Artery Disease
-
Abstract Number: PB0206
Characterisation and Evaluation of a Candidate Bethesda Assay Reference Reagent Developed from Recombinant, Patient-Derived FVIII Inhibitors
-
Abstract Number: PB2187
Characterisation of a Novel F5 Gene Mutation (Ala2114Asp, Factor V Besançon) Associated with Factor V Deficiency and Recurrent Venous Thrombosis
-
Abstract Number: PB2240
Characterisation of Antithrombin p.Thr147Ala, the First Common Founder Variant from African Origin Responsible for Inherited Antithrombin Deficiency
-
Abstract Number: PB0376
Characterisation of Plasma Microvesicles in Type 2 Diabetes mellitus Patients with and without Microalbuminuria
-
Abstract Number: PB2340
Characterising the Burden of Hospital-acquired Venous Thromboembolism Arising during Admission and Following Discharge in an Irish Hospital Group Serving a Population of over One Million Individuals
-
Abstract Number: PB1374
Characteristics and Outcome of Patients with Thrombocytopenia Secondary to Acute Cytomegalovirus Infection: Case Series and Literature Review
-
Abstract Number: PB0107
Characteristics and Recurrence of Acute Ischemic Stroke in Children: An Examination Using Real World Data
-
Abstract Number: PB1319
Characteristics of Patients with Cyclic Thrombocytopenia: An Observational Cohort Study
-
Abstract Number: PB0101
Characterization and Antithrombotic Treatment of Patients with Acute Ischemic Stroke and No Atrial Fibrillation: A Real-world Study
-
Abstract Number: PB1195
Characterization and Management of Patients with Mild or Moderate Hereditary Factor X Deficiency: A Retrospective Chart Review
-
Abstract Number: PB1155
Characterization of Factor IX-FIAV: A Factor IX Variant that Displays Cofactor-Independent Activity
-
Abstract Number: PB1413
Characterization of Murine Monoclonal Anti-PF4/Polyanion Antibodies, as Potential Useful Tools for Studies on Typical and Autoimmune HIT
-
Abstract Number: PB1159
Characterization of Neutralizing Anti-emicizumab Antibody Developed in a Hemophilia A Patient
-
Abstract Number: PB1644
Characterization of the Hypercoagulable State and NETosis in Systemic Lupus Erythematosus
-
Abstract Number: OC 08.5
Characterization of the Protein Profile in Thrombi of Patients with Ischemic Stroke and Identification of Potential Biomarkers as Predictors of Negative Clinical Evolution
-
Abstract Number: PB1699
Characterization of Thrombus Heterogeneity and Dynamics of Formation on Collagen Spots in a Parallel-plate Flow Chamber
-
Abstract Number: PB1548
Characterization of Type 2B VWD in the US Zimmerman Program
-
Abstract Number: PB2049
Characterization of VKA Control in Patients with Thrombotic and Major Hemorrhagic Events in Anticoagulation Hematology Units: Results from the EVENTHO Study
-
Abstract Number: PB1659
Characterizing Platelet Granules of von Willebrand Disease Patients Using Super-Resolution Structured Illumination Microscopy
-
Abstract Number: OC 02.2
Chemical Modulation of Fibrinogen Production and its Impact on Venous Thrombosis
-
Abstract Number: PB1807
Chemotherapy – Induced Thrombocytopenia in Pediatric Acute Lymphoblastic Leukemia: A Single-institution Report
-
Abstract Number: PB1236
Chronic Refractory Immune Thrombocytopenia is Associated with a High Frequency of Potentially Damaging Variants in Immune Genes
-
Abstract Number: PB1769
Chronically Elevated Interleukin-6 Levels in Mice Lead to a Disturbance in the Coagulation System
-
Abstract Number: PB0465
Circulating MicroRNA Levels Indicate Platelet Activation in Endotoxemia Despite Platelet P2Y12 Inhibition
-
Abstract Number: PB0437
Circulating MicroRNAs and Platelet Extracellular Vesicles as Novel Biomarkers in Acute Ischaemic Stroke
-
Abstract Number: PB1404
Circulating Myeloid-related Protein (MRP)-8/14 May Contribute to Suboptimal Response to Low Dose Aspirin in Patients with Type 2 Diabetes mellitus
-
Abstract Number: PB0209
Circulating T Helper 17 Cells (Th17) Increase at a Higher Rate than Tregs in Previously Untreated Patients with Severe Hemophilia A Who Develop Inhibitors During the First 50 Exposure Days to rFVIII
-
Abstract Number: PB1932
CliA Immunoassay: Better Identification of High Thrombotic Risk Triple Positive Antiphospholipid Patients
-
Abstract Number: PB1867
Clinical Analysis of 83 Patients with Thrombotic Thrombocytopenic Purpura
-
Abstract Number: PB/CO02
Clinical and Computed Tomography Characteristics of COVID-19 Associated Acute Pulmonary Embolism: A Different Phenotype of Thrombotic Disease?
-
Abstract Number: PB1889
Clinical and Economic Impacts of a New Rapid ADAMTS-13 Assay for the Diagnosis of Suspected Thrombotic Thrombocytopenic Purpura
-
Abstract Number: PB2186
Clinical and Laboratory Characteristics of Patients with Hereditary Thrombophilias in the North-Western Region of Russia
-
Abstract Number: PB1340
Clinical and Laboratory Factors Affecting Chronicity in Children Diagnosed with Immune Thrombocytopenia
-
Abstract Number: PB1495
Clinical and Molecular Characterization of Chinese Patients with Wiskott-Aldrich Syndrome
-
Abstract Number: PB1561
Clinical and Phenotypic Evaluation of Patients with Low von Willebrand Factor
-
Abstract Number: PB1304
Clinical and Radiological Outcome in a Single Center Cohort of Pediatric Patients with Focal Cerebral Arteriopathy (FCA). Safety of Antithrombotic Prophylaxis and Therapy
-
Abstract Number: PB2040
Clinical Case: Reversal of Dabigatran Levels in Patients with Renal Insufficiency that Have Required the use of Idarucizumab
-
Abstract Number: PB2448
Clinical Characteristics and Outcomes of Non-cancer, Non-CVC Associated upper Extremity DVT
-
Abstract Number: PB1171
Clinical Characteristics of Patients with Rare Bleeding Disorders: Real-Life Data from the Netherlands (RBiN Study)
-
Abstract Number: PB0613
Clinical Exomes for the Diagnosis of Inherited Bleeding, Thrombotic and Platelet Disorders: The Belgian Experience
-
Abstract Number: PB1094
Clinical Immunogenicity of Valoctocogene Roxaparvovec in GENEr8-1, a Phase 3 Study of AAV5-Mediated Gene Therapy Encoding Human FVIII for the Treatment of Hemophilia A
-
Abstract Number: PB0077
Clinical Implications of White Blood Cell Count and Platelet Indices in Individuals with Risk Factor of Coronary Artery Disease
-
Abstract Number: PB1080
Clinical Improvement of Haemophilic Arthropathy in a Female Pediatric Patient with Severe Hemophilia A Following Treatment with Emicizumab
-
Abstract Number: PB2352
Clinical Indications and Efficacy of Low Molecular Weight Heparin (LMWH) in Pregnancy
-
Abstract Number: PB2102
Clinical Outcome of Anticoagulation for Acute Venous Thromboembolism Associated with Different Types of Cancer
-
Abstract Number: PB2146
Clinical Outcome of Splanchnic and Usual Site Venous Thrombosis in Patients with Solid Cancer
-
Abstract Number: PB0288
Clinical Outcome of Using Three-Factor Prothrombin Complex Concentrate in Patients with Major Bleeding Associated with Factor Xa Inhibitor
-
Abstract Number: PB2064
Clinical Outcomes for Patients of High Body Weight on Apixaban or Rivaroxaban
-
Abstract Number: PB0600
Clinical Performance of the Tina-Quant D-Dimer Gen 2 Assay on the Cobas t 711 Analyser for Evaluation of Patients with Suspected Deep Vein Thrombosis (DVT) and/or Pulmonary Embolism (PE)
-
Abstract Number: PB1347
Clinical Practise of SMOG System for Assessing Severity of Hemorrhagic Manifestations of Immume Thrombocytopenia (ITP) in Children
-
Abstract Number: PB0388
Clinical Presentation and Management of Homozygous Protein C Deficiency: Cukurova Experience
-
Abstract Number: PB2176
Clinical Presentation and Outcomes of Cancer-associated Distal Deep Vein Thrombosis: Data from the RIETE Registry
-
Abstract Number: PB1538
Clinical Presentation of Von Willebrand Disease in a Developing Country-A Cross Sectional Study
-
Abstract Number: PB0872
Clinical Review of Patients with Haemophilia (PwH) in a Malaysian Tertiary Center
-
Abstract Number: PB0216
Clinical Significance of T-cell Subsets for the Inhibitor Development in Pediatric Hemophilia A Patients
-
Abstract Number: PB2317
Clinical Spectrum and Prothrombotic Risk Factors of Cerebral Venous Sinus Thrombosis in Children
-
Abstract Number: PB0309
Clinical Study of Children’s Intracranial Hemorrhage in Single Hemophilia Center in China
-
Abstract Number: PB1440
Clinical Use of Carica Papaya Leaf Extract in Thrombocytopenia in Bernard-Soulier Syndrome
-
Abstract Number: PB0696
Clinical Utilization of Lupus Anticoagulant Testing in a Large Hospital System
-
Abstract Number: PB0996
Clinical Validation of Population Pharmacokinetic Model for Plasma-Derived Factor VIII/VWF Comparing 3 Years Follow-up
-
Abstract Number: PB0575
Clinical Validation of the T-TAS 01 PL Assay in Patients Taking Antiplatelet Therapy
-
Abstract Number: PB0574
Clinical Validation of the T-TAS 01 PL Assay in Patients with von Willebrand Disease and Glanzmann´s Thrombasthenia
-
Abstract Number: PB1438
Clinical, Morphological and Functional Platelet Tests in Inherited Thrombocytopenia
-
Abstract Number: PB1557
Clinically Relevant Differences between Two New Generation VWF: GPIbR Assays in a Patient with Acquired von Willebrand Syndrome – Case Report
-
Abstract Number: PB0689
Clinically Significant Disagreement between Point-of-Care INR and Central Laboratory-assessed INR in Acute Stroke Patients
-
Abstract Number: PB1503
Clinico-pathological Spectrum of GlanzmannThrombasthenia
-
Abstract Number: PB0001
Clopidogrel Resistance and P2y12 Receptor Gene Polymorphisms in Patients with Non-ST Elevated Acute Coronary Syndrome
-
Abstract Number: PB0458
Clot Contraction Drives Structural Redistribution of Platelets, Fibrin and Red Blood Cells through Active Cell Sorting
-
Abstract Number: PB0018
Clot Formation, Ultrastructure and Lysis in Patients with Acute Phase Myocardial Infarction
-
Abstract Number: OC 06.3
Clotting Promotes Glioblastoma Progression
-
Abstract Number: PB1286
Coagulation Activation Via Extrinsic Pathway Is the Major Cause of Hypercoagulation in Newborns during First Days of Life
-
Abstract Number: PB0789
Coagulation and Inflammation Genes Are Differently Expressed during the Acquired Coagulation Disorder Induced by Snake Envenomation
-
Abstract Number: PB0250
Coagulation Assays Based on Surface-Mimicking Antibodies against Factor XII
-
Abstract Number: PB0415
Coagulation Factor IIIa (f3a) Knockdown in Zebrafish Leads to Defective Angiogenesis and Bleeding Phenotype
-
Abstract Number: PB0413
Coagulation Factor Xa [(Recombinant) Andexxa®] for Reversal of Apixaban and Rivaroxaban in Patients Diagnosed with Intracranial Hemorrhage
-
Abstract Number: PB1790
Coagulation Factor XII Binds to the Opportunistic Pathogen, Candida albicans and Promotes Biofilm Formation
-
Abstract Number: PB1776
Coagulation Factor XII Signaling Triggers Inflammasome-associated Renal Damage in Diabetic Nephropathy
-
Abstract Number: PB1778
Coagulation Markers, Neutrophil Extracellular Traps and Thrombin Generation Test, in the Detection and Risk Stratification of Prostate Cancer
-
Abstract Number: PB1788
Coagulation Profile in Patients with Pneumonia Assessed by Thrombin Generation Procedures
-
Abstract Number: PB0283
Coagulation Research in Paediatric ECMO: Delayed Consent to Improve Enrolment
-
Abstract Number: PB0285
Coagulation Research in Paediatric ECMO: The Need for a Common Languagecoagulation Research in Paediatric ECMO: The Need for a Common Language
-
Abstract Number: PB0800
Coagulopathy in Pediatric Patients with Hemophagocytic Lymphohistiocytosis
-
Abstract Number: PB1909
Cohort of Patients with Triple Antiphospholipid Antibodies: Differences between Asymptomatic and Symptomatic Individuals
-
Abstract Number: PB0944
Coinfection by Hepatitis B, C and HIV in Patients with Haemophilia
-
Abstract Number: PB1625
Cold over Room Temperature Storage of Apheresis Platelets Better Preserves Hemostatic Function out to 21 Days
-
Abstract Number: PB1832
Cold Storage of Apheresis Platelets Promotes IL-8 Release in Platelet: Leukocyte Co-cultures
-
Abstract Number: PB1182
Collagen Turnover and Plasma Ascorbic Acid Levels in Patients Suspected of Inherited Bleeding Disorders Harboring Variants in Collagen-related Genes
-
Abstract Number: PB1650
Collagen-Induced Thrombocyte Aggregation in Essential Arterial Hypertension with Subclinical Organ Damage
-
Abstract Number: PB1959
Colonization with the Minimal Microbial Consortium Altered Schaedler Flora Hampers the Formation of Neutrophil Extracellular Traps in Acute Mesenteric Ischemia-Reperfusion Injury
-
Abstract Number: OC 13.3
Combination of New Homozygous MPIG6B and SH2B3 Variants Leads to Early Onset Myelofibrosis, Thrombocytopenia and Abnormal Platelet Function
-
Abstract Number: PB0220
Combined Analysis of Dendritic Cell (DC) HLA-class-II (HLAcII) Peptidomic Profiling Data Derived from Different Therapeutic Factor VIII Proteins (tFVIIIs) in Independent Experiments/Laboratories
-
Abstract Number: PB1191
Combined Factor Deficiencies Rare among the Rare Bleeding Disorders among Pediatric Population, Seven Years Experience in a Tertiary Care Center of Lahore, Pakistan
-
Abstract Number: PB1106
Combined Gene and Cell Therapy for the Treatment of Hemophilia A within an Implantable Therapeutic Device
-
Abstract Number: PB1597
Combined α4a- and β1-Tubulin Deficiencies Profoundly Affect Platelet Biogenesis and Haemostasis
-
Abstract Number: PB0968
Comorbidities in Patients with Severe Haemophilia: Birth Cohort Analysis of Taiwan Society of Thrombosis and Hemostasis Database
-
Abstract Number: PB1021
Comorbidities of Hemophilia & Factor XIII Deficiency Patients
-
Abstract Number: PB0324
Comparative Analysis of the Coagulometric and Chromogenic Methods for the Determination of Factor VIII Activity in the Plasma of Patients Suspected with Blood Coagulation Disorders
-
Abstract Number: PB1208
Comparative Analysis of Three Custom Gene Panels Based on Next Generation Sequencing for Diagnostic of Inherited Coagulation Bleeding Disorders
-
Abstract Number: PB0563
Comparative Evaluation of the Aggregation Studies in a Sysmex CS2500 Coagulometer with a Standard Turbidimetric Technique
-
Abstract Number: PB0319
Comparative Pharmacokinetics of Two Recombinant FVIII Concentrates in Chinese Pediatric Patients with Severe Hemophilia A: A Single-Center Study
-
Abstract Number: PB2268
Comparative Study between Thromboelastography and Conventional Coagulation Tests in Deep Vein Thrombosis
-
Abstract Number: PB2506
Comparative Study of the Clinical Application of Two Bleeding Grading Systems for Pregnant Women with Immune Thrombocytopenia (ITP)
-
Abstract Number: PB0051
Comparison and Association of Fibrinogen, von Willibrand Factor and Factor VIII Levels with Risk of Cardiovascular Disease in Cigarette Smokers Residing in Calabar Metropolis, Nigeria
-
Abstract Number: PB1254
Comparison between Bleeding Time and PFA-200 to Evaluate Platelet Function Disorder in Children
-
Abstract Number: PB0725
Comparison Natural History and Genotype of 31 Patients with Inherited Dysfibrinogenemia
-
Abstract Number: PB0289
Comparison of a New Point-of-Care Hemostasis Analyzer with Laboratory Parameters in Patients with Veno-venous Extracorporeal Membrane Oxygenation
-
Abstract Number: PB0546
Comparison of a Novel Viscoelastic Device with Standard Laboratory Tests for its Clinical Validation in Peri-Operative Cardiac Patients
-
Abstract Number: PB0165
Comparison of a Validated UHPLC-MS/MS Method and Chromogenic Anti-Xa Assays from Different Manufacturer for the Assessment of Edoxaban and its M4 Metabolite Levels in Plasma
-
Abstract Number: PB1528
Comparison of an Automated von Willebrand Factor Activity Assay by HemosIL Werfen® with Ristocetin Cofactor Assay by Aggregometry in Thrombocytic Patients with Myeloproliferative Neoplasms or Secondary Thrombocytosis
-
Abstract Number: PB0970
Comparison of Bleeding Pattern and Inhibitor Development among Hemophilia Patients: Prophylactic versus On-Demand Treatment
-
Abstract Number: PB1148
Comparison of Bypassing Agents in Patients on Emicizumab Using Global Hemostasis Assays
-
Abstract Number: PB1418
Comparison of Clinical Adverse Events during Empiric Therapy for Patients with Suspected HIT
-
Abstract Number: PB1118
Comparison of Coagulation Parameters Associated with Fibrinogen Concentrate and Cryoprecipitate for Treatment of Bleeding in Patients Undergoing Cytoreductive Surgery for Pseudomyxoma Peritonei: Results from the FORMA-05 Study
-
Abstract Number: PB0637
Comparison of Different Stago Instruments for Fibrinogen Level Assessment with STA-liquid Fib
-
Abstract Number: PB0898
Comparison of FVIII Prophylaxis Treatment Regimen and Associated Clinical Outcomes between rVIII-SingleChain and Other rFVIII Products Commonly Used in Italian Hemophilia A Patients
-
Abstract Number: PB0203
Comparison of Medication Adherence Between Different Oral Anticoagulants: A Propensity Weighted Nationwide Cohort Study
-
Abstract Number: PB0543
Comparison of New Scoring System of Platelet Aggregation on Automated Coagulation Analyzer CN-6000 with CS-5100
-
Abstract Number: PB1395
Comparison of Platelet Function Testing in Patients Undergoing Neuroradiological Flow Diversion Stents
-
Abstract Number: PB1798
Comparison of Platelet Parameters in the Patients with JAK2 V617F Mutated Essential Thrombocytosis and Reactive Thrombocytosis
-
Abstract Number: OC 11.2
Comparison of Recommended Postpartum Thromboprophylaxis and of Absolute Risk Thresholds According to the RCOG, ACCP and ACOG Guidelines
-
Abstract Number: PB0520
Comparison of the Biophen® Heparin LRT with the HemosIL® Liquid Anti-Xa Assay for the Measurement of Apixaban, Edoxaban and Rivaroxaban
-
Abstract Number: PB0594
Comparison of the One-Stage Clot-Based and Chromogenic Factor VIII Activity Measurement
-
Abstract Number: PB0576
Comparison of the T-TAS 01 PL Assay with PFA-100 for Assessment of Primary Hemostatic Function
-
Abstract Number: PB0664
Comparison of Thromboelastography with T2MR Data
-
Abstract Number: PB0698
Comparison of Thromboelastometry by ROTEM® Delta and ROTEM® Sigma in Obese Patients
-
Abstract Number: PB0560
Comparison of Two Quantitative Methods for Determination of Dabigatran Concentration: Diluted Thrombin Time Test and Innovance Dabigatran Test in Real Life Patients Treated with Dabigatran
-
Abstract Number: PB1364
Comparison of Various Diagnostic Methods in Assessing Platelet Count in Patients with Immunotrombocytopenia
-
Abstract Number: PB0590
Comparison of Visual versus Reader Results of the Point of Care Test of Direct Oral Anticoagulants from Urine Samples
-
Abstract Number: PB1580
Comparison of von Willebrand Factor (VWF) Multimeric Profile Obtained by a Commercial Electrophoretic Test (Hydragel 5 von Willebrand Multimers) and Classical Home-made with a Discontinuous 1% Agarose Gel Electrophoresis
-
Abstract Number: PB1783
Complement Mannan-Binding-Lectin Is Associated with Activated Platelets during Clot Formation in a Microfluidic Bleeding Model
-
Abstract Number: PB1945
Complement Pathway and Endothelial Dysfunction in Severe Preeclampsia
-
Abstract Number: OC 05.5
Complement Regulator Factor H is a Cofactor for Thrombin in both Pro- and Anticoagulant Roles
-
Abstract Number: PB1925
Complement Regulatory Abnormalities are Frequent in Patients with Catastrophic APS and Refractory Patients Respond Rapidly to Eculizumab Treatment
-
Abstract Number: PB1470
Complex Changes in Plasma Associated with Platelet Dysfunction in Trauma Patients
-
Abstract Number: PB0450
Comprehensive Platelet Phenotyping Supports the Role of Platelets in the Pathogenesis of Acute Venous Thromboembolism – Results from Clinical Observational Studies
-
Abstract Number: PB2451
Concentration Levels of Direct Oral Anticoagulants and Clinical Relevance in a Tertiary Hospital
-
Abstract Number: PB0819
Concizumab Does Not Affect Activated Partial Thromboplastin Time, Prothrombin Time or Factor VIII/IX Activity Measured Using One-Stage Clotting or Chromogenic Substrate Assays
-
Abstract Number: PB2085
Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation
-
Abstract Number: PB1198
Congenital Afibrinogenemia. Report of a Case in the Children´S Hospital of Mexico Federico Gomez
-
Abstract Number: PB1190
Congenital Combined Bleeding Disorders, a Study on a Large Number of Iranian Patients
-
Abstract Number: PB0190
Congenital Factor X Deficiency with Isolated Prothrombin Time Prolongation
-
Abstract Number: PB0719
Congenital Qualitative Fibrinogen Disorders: Case Series from Argentina; Multicentric Collaborative Study
-
Abstract Number: PB1092
Consistent Structural Kinetics of Valoctocogene Roxaparvovec DNA in Human Blood Samples
-
Abstract Number: PB1117
Continuous Infusion with Kovaltry (Octocog Alfa) during Cardiac Surgery for Tetralogy of Fallot in an Hemophilic Child
-
Abstract Number: PB1933
Contribution of Beta2 Glycoprotein1 IgA (B2GP1 IgA) Antibodies Research in Diagnosis of Seronegative Antiphospholipid Syndrome in Cerebral Thrombosis: A Case Series of 21 Patients
-
Abstract Number: PB0007
Contribution of Fibrin and von Willebrand Factor to Platelet Adhesion on Ruptured Atherosclerotic Plaque in Acute Myocardial Infarction
-
Abstract Number: PB0815
Contributions of the Individual Components of an Activated Prothrombin Complex Concentrate to Thrombin Generation in the Presence of Emicizumab
-
Abstract Number: PB2165
Cooperation about the Treatment of the Venous Thromboembolism in Cancer Institute Hospitals and Neighboring Cooperation Acute Hospitals
-
Abstract Number: PB0266
Corn Trypsin Inhibitor in the Preanalytical Phase of Contact Activation Assays
-
Abstract Number: PB1143
Correction of Human Hemophilia B Gene in iPSCs by Base-Editing Approach Based on Engineered Cas9 with Broad PAM Flexibility
-
Abstract Number: PB0399
Correlation between ADAMTS13 and VAP1 Levels in Multiple Sclerosis with Cerebral Microbleeds
-
Abstract Number: PB2475
Correlation between Anti-Xa Activity and Plasmatic Levels of Apixaban
-
Abstract Number: PB0617
Correlation between INR Pocket Test and Standard Coagulation Test
-
Abstract Number: PB2326
Correlation between Intrinsic D-Dimer Levels and D-Dimer Measured at First Venous Thromboembolism (VTE)
-
Abstract Number: PB1884
Correlation between Phenotype-genotype versus in-silico Prediction of Novel and Known Disease-causing Variants in Upshaw-Schulman Syndrome Patients in a Single Institution of Argentina
-
Abstract Number: PB0384
Correlation between Protein C and CCL18 Levels in Multiple Sclerosis
-
Abstract Number: PB0540
Correlation between the VerifyNow P2Y12 Assay and the Newly-Developed APAL System in Neuroendovascular Patients
-
Abstract Number: PB0578
Correlation between Thrombin Generation and Prothrombin Fragment F1+2 Plasma Levels
-
Abstract Number: PB1498
Correlation GLATIT Scores and the Number of Bleeding Episodes in the Assessment of the Prognosis of Inherited Platelet Disorder
-
Abstract Number: PB0003
Correlation of D-Dimer Levels with Troponin I in Patients with Acute Myocardial Infarction
-
Abstract Number: PB2473
Correlation of Reperfusion Therapy and In-hospital Mortality in Patients with Intermediate Risk Acute Pulmonary Embolism and Right Ventricular Dysfunction
-
Abstract Number: PB1406
Correlation of VASP Phosphorylation Assay with Light Transmission Aggregometry for Patients Treated with Clopidogrel or Ticagrelor
-
Abstract Number: PB1048
Correlations of Von Willebrand Factor Levels, Factor VIII (FVIII) Pharmacokinetics and Prophylaxis Dose in Severe Haemophilia A Patients Switching to rFVIII-Fc Studied by Individual and Population Tool-assisted PK Assessments
-
Abstract Number: PB1378
Corticosteroid Reduction or Discontinuation after Initiation of Avatrombopag Treatment in Patients with Chronic Immune Thrombocytopenia (ITP)
-
Abstract Number: PB2284
Cost-Effectiveness of Magnetic Resonance Direct Thrombus Imaging for Diagnosing Recurrent Ipsilateral Deep Vein Thrombosis
-
Abstract Number: PB0768
Covalent Prourokinase-dendrimer Complexes with Increased Plasma Stability and High Thrombolytic Activity in vitro
-
Abstract Number: PB/CO21
COVID-19 Pandemic: Dissecting Coagulation apart from Inflammation
-
Abstract Number: PB0141
CRISPR/Cas9-Mediated Generation of a RUNX1 Knock-In Mice Model and Platelet Characterization
-
Abstract Number: PB1844
Critical Role for Platelet Ral GTPases in the Regulation of Venous Thrombosis
-
Abstract Number: PB1843
Critical Role of Platelets during Pulmonary Fibrosis
-
Abstract Number: PB0470
Cross-sectional Study of Thrombin Generation and Overall Hemostatic Potential in a Cohort Clinically Investigated for Thrombophilia
-
Abstract Number: PB1768
Cross-Talk of Activated Protein C(aPC) with Integrin and its Effect on T-Cell Signaling
-
Abstract Number: PB0056
Crosstalk between Platelet and Endothelial Dysfunction in Survivors of Allogeneic Hematopoietic Cell Transplantation Independently of Traditional Cardiovascular Risk Assessment
-
Abstract Number: PB1953
CTL-2 is a VWF Receptor Involved in Neutrophil Activation
-
Abstract Number: PB0912
Current Challenges in Diagnosis and Management of Hemophilia Afghanistan
-
Abstract Number: PB1513
Current Data About Arterial Thrombotic Events in Cerebrovascular Circulation Caused by Sticky Platelet Syndrome in the National Registry of Thrombophilic States in Slovak Republic
-
Abstract Number: PB1864
Current Possibilities of ADAMTS 13 Diagnostics – Advantages and Limitations
-
Abstract Number: PB2135
Current Status on Non-hematological Cancer Associated Thrombosis at Tertiary Care Hospital in India
-
Abstract Number: PB2007
Cytokine Network Architecture at the Endothelial Interface
ISTH 2020 Congress
July 12-14, 2020. Virtual Congress.